Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1955 1
1960 1
1964 1
1975 2
1976 4
1977 4
1978 2
1979 5
1980 5
1981 5
1982 5
1983 2
1984 5
1985 9
1986 1
1987 11
1988 4
1989 4
1990 10
1991 9
1992 9
1993 7
1994 9
1995 12
1996 14
1997 12
1998 27
1999 13
2000 23
2001 15
2002 27
2003 35
2004 45
2005 38
2006 48
2007 66
2008 72
2009 72
2010 84
2011 79
2012 101
2013 118
2014 101
2015 104
2016 108
2017 120
2018 119
2019 111
2020 136
2021 124
2022 144
2023 119
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

2,036 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment.
Samsu N. Samsu N. Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. eCollection 2021. Biomed Res Int. 2021. PMID: 34307650 Free PMC article. Review.
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease worldwide. Chronic hyperglycemia and high blood pressure are the main risk factors for the development of DN. ...In fact, the prevalence of DN continues to increase, and additional therapy is …
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease worldwide. Chronic hyperglycemia and high blood pressure ar …
Gestational Diabetes: Overview with Emphasis on Medical Management.
Lende M, Rijhsinghani A. Lende M, et al. Int J Environ Res Public Health. 2020 Dec 21;17(24):9573. doi: 10.3390/ijerph17249573. Int J Environ Res Public Health. 2020. PMID: 33371325 Free PMC article. Review.
However, management of GDM continues to be varied, and currently several options are available for treatment of hyperglycemia during pregnancy. A review of various aspects of GDM is discussed with a focus on the medical management during pregnancy, as practiced in the Unit …
However, management of GDM continues to be varied, and currently several options are available for treatment of hyperglycemia during …
Diagnosis and classification of diabetes mellitus: new criteria.
Mayfield J. Mayfield J. Am Fam Physician. 1998 Oct 15;58(6):1355-62, 1369-70. Am Fam Physician. 1998. PMID: 9803200 Free article. Review.
These changes provide an easier and more reliable means of diagnosing persons at risk of complications from hyperglycemia. Currently, only one half of the people who have diabetes mellitus have been diagnosed. ...
These changes provide an easier and more reliable means of diagnosing persons at risk of complications from hyperglycemia. Currently, …
Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline.
Korytkowski MT, Muniyappa R, Antinori-Lent K, Donihi AC, Drincic AT, Hirsch IB, Luger A, McDonnell ME, Murad MH, Nielsen C, Pegg C, Rushakoff RJ, Santesso N, Umpierrez GE. Korytkowski MT, et al. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2101-2128. doi: 10.1210/clinem/dgac278. J Clin Endocrinol Metab. 2022. PMID: 35690958 Free PMC article.
These patients are at increased risk for adverse clinical outcomes in the absence of defined approaches to glycemic management. OBJECTIVE: To review and update the 2012 Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Settings: An Endocrine …
These patients are at increased risk for adverse clinical outcomes in the absence of defined approaches to glycemic management. OBJECTIVE: T …
Diabetes Mellitus: Screening and Diagnosis.
Pippitt K, Li M, Gurgle HE. Pippitt K, et al. Am Fam Physician. 2016 Jan 15;93(2):103-9. Am Fam Physician. 2016. PMID: 26926406 Free article. Review.
Results should be confirmed with repeat testing on a subsequent day; however, a single random plasma glucose level of 200 mg per dL or greater with typical signs and symptoms of hyperglycemia likely indicates diabetes. Additional testing to determine the etiology of diabet …
Results should be confirmed with repeat testing on a subsequent day; however, a single random plasma glucose level of 200 mg per dL or great …
Diabetic macular edema: Evidence-based management.
Browning DJ, Stewart MW, Lee C. Browning DJ, et al. Indian J Ophthalmol. 2018 Dec;66(12):1736-1750. doi: 10.4103/ijo.IJO_1240_18. Indian J Ophthalmol. 2018. PMID: 30451174 Free PMC article. Review.
Spectral domain optical coherence tomography (SD-OCT) is the cornerstone of clinical assessment of DME. The foundation of treatment is metabolic control of hyperglycemia and blood pressure. Specific ophthalmic treatments include intravitreal anti-VEGF drug injections, intr …
Spectral domain optical coherence tomography (SD-OCT) is the cornerstone of clinical assessment of DME. The foundation of treatment is metab …
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes.
Park JJ. Park JJ. Diabetes Metab J. 2021 Mar;45(2):146-157. doi: 10.4093/dmj.2020.0282. Epub 2021 Mar 25. Diabetes Metab J. 2021. PMID: 33813813 Free PMC article. Review.
Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. ...Therefore, all HFrEF patients sho …
Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyp …
Neonatal Diabetes Mellitus: An Update on Diagnosis and Management.
Lemelman MB, Letourneau L, Greeley SAW. Lemelman MB, et al. Clin Perinatol. 2018 Mar;45(1):41-59. doi: 10.1016/j.clp.2017.10.006. Epub 2017 Dec 16. Clin Perinatol. 2018. PMID: 29406006 Free PMC article. Review.
It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infection, stress, inadequate pancreatic insulin production in preterm infants, among others. ...
It is important to distinguish neonatal diabetes mellitus from other causes of hyperglycemia in newborns. Other causes include infect …
Diabetic nephropathy: diagnosis, prevention, and treatment.
Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Gross JL, et al. Diabetes Care. 2005 Jan;28(1):164-76. doi: 10.2337/diacare.28.1.164. Diabetes Care. 2005. PMID: 15616252 Review.
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects approximately 40% of type 1 and type 2 diabetic patients. ...Diabetic nephropathy is categorized into stages: microalbuminuria (UAE >20 microg/min and …
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects approximately …
Potential of Creatine in Glucose Management and Diabetes.
Solis MY, Artioli GG, Gualano B. Solis MY, et al. Nutrients. 2021 Feb 9;13(2):570. doi: 10.3390/nu13020570. Nutrients. 2021. PMID: 33572228 Free PMC article. Review.
Creatine is one of the most popular supplements worldwide, and it is frequently used by both athletic and non-athletic populations to improve power, strength, muscle mass and performance. A growing body of evidence has been identified potential therapeutic effects of creat …
Creatine is one of the most popular supplements worldwide, and it is frequently used by both athletic and non-athletic populations to improv …
2,036 results